GRI CIK: 1824293

GRI Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
8.13
FY22:
0.31
FY23:
2.93
FY24:
5.62
FY25:
8.59
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.21
FY22:
0.07
FY23:
0.02
FY24:
0.12
FY25:
0.07
Total assets
Change from FY21 to FY25
millions USD
FY21:
8.34
FY22:
0.38
FY23:
2.96
FY24:
5.74
FY25:
8.67

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.45
FY22:
1.99
FY23:
2.70
FY24:
1.64
FY25:
2.64
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.07
FY22:
0.01
FY23:
0
FY24:
0.07
FY25:
0.02
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.82
FY22:
−1.63
FY23:
0.26
FY24:
4.03
FY25:
6.01
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
8.34
FY22:
0.38
FY23:
2.96
FY24:
5.74
FY25:
8.67

All amounts in millions USD Data source:SEC EDGAR